Coating Reduces Encrustation on Urethral Stent

Information

  • Research Project
  • 6792834
  • ApplicationId
    6792834
  • Core Project Number
    R43DK067768
  • Full Project Number
    1R43DK067768-01
  • Serial Number
    67768
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/2004 - 20 years ago
  • Project End Date
    10/31/2004 - 20 years ago
  • Program Officer Name
    MULLINS, CHRISTOPHER V.
  • Budget Start Date
    5/1/2004 - 20 years ago
  • Budget End Date
    10/31/2004 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/23/2004 - 20 years ago
Organizations

Coating Reduces Encrustation on Urethral Stent

DESCRIPTION (provided by applicant): The long-term objective of the proposed research is to provide an effective surface coating to reduce encrustation on urinary devices. Encrustation is one of the major complications associated with them, with an overall incidence of 10-58%, but a higher (64%) incidence in stone formers. To reduce this complication, we proposed to use a barrier coating to protect devices from pH elevation. Specific aim 1 is to establish an experimental model to create encrustation on testing subjects. The model is an in vitro, static incubation system with humidity and temperature control. With this model, specific aim 2 will test the hypothesis-constant surface pH reduces encrustation. Evaluation will be made based on the measurements of calcium deposition on testing subjects exposed to various pH conditions. Specific aim 3 concentrates on prolonging the effectiveness of anti-encrustation. The extension of effectiveness could be achieved by increasing the amount of active ingredients in the coating. The last specific aim is to evaluate the commercial potential of this new coating. Ureteral stents equipped with the anti-encrustation coating will be compared to many similar products on the market in the aspect of encrustation severity. The data will guide future optimization.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99257
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:99257\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AST PRODUCTS, INC.
  • Organization Department
  • Organization DUNS
    611655440
  • Organization City
    BILLERICA
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01821
  • Organization District
    UNITED STATES